Anxiolytic properties of A(1) adenosine receptor PAMs

por Vincenzi, Fabrizio, Borea, Pier Andrea, Varani, Katia
Publicado 2016

Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain

por Vincenzi, Fabrizio, Pasquini, Silvia, Borea, Pier Andrea, Varani, Katia
Publicado 2020

Adenosine and Inflammation: Here, There and Everywhere

por Pasquini, Silvia, Contri, Chiara, Borea, Pier Andrea, Vincenzi, Fabrizio, Varani, Katia
Publicado 2021

Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications

por Pasquini, Silvia, Contri, Chiara, Cappello, Martina, Borea, Pier Andrea, Varani, Katia, Vincenzi, Fabrizio
Publicado 2022

Piperazine- and Piperidine-Containing Thiazolo[5,4-d]pyrimidine Derivatives as New Potent and Selective Adenosine A(2A) Receptor Inverse Agonists

por Varano, Flavia, Catarzi, Daniela, Vigiani, Erica, Vincenzi, Fabrizio, Pasquini, Silvia, Varani, Katia, Colotta, Vittoria
Publicado 2020

A(3) Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma

por Vincenzi, Fabrizio, Rotondo, John Charles, Pasquini, Silvia, Di Virgilio, Francesco, Varani, Katia, Tognon, Mauro
Publicado 2021

Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice

por Domenicale, Chiara, Mercatelli, Daniela, Albanese, Federica, Novello, Salvatore, Vincenzi, Fabrizio, Varani, Katia, Morari, Michele
Publicado 2022

A(2A )and A(3 )adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and met...

por Varani, Katia, Padovan, Melissa, Vincenzi, Fabrizio, Targa, Martina, Trotta, Francesco, Govoni, Marcello, Borea, Pier Andrea
Publicado 2011

A(2A) adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus

por Bortoluzzi, Alessandra, Vincenzi, Fabrizio, Govoni, Marcello, Padovan, Melissa, Ravani, Annalisa, Borea, Pier Andrea, Varani, Katia
Publicado 2016

The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A(1)AR Positive Allosteric Modulation

por Vincenzi, Fabrizio, Pasquini, Silvia, Gessi, Stefania, Merighi, Stefania, Romagnoli, Romeo, Borea, Pier Andrea, Varani, Katia
Publicado 2020

Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-like SH-SY5Y Cells from Oxygen-Glucose Deprivation

por Vincenzi, Fabrizio, Pasquini, Silvia, Setti, Stefania, Salati, Simona, Cadossi, Ruggero, Borea, Pier Andrea, Varani, Katia
Publicado 2020

A(1) Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?

por Vincenzi, Fabrizio, Pasquini, Silvia, Battistello, Enrica, Merighi, Stefania, Gessi, Stefania, Borea, Pier Andrea, Varani, Katia
Publicado 2020

Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications

por Varani, Katia, Vincenzi, Fabrizio, Pasquini, Silvia, Blo, Irene, Salati, Simona, Cadossi, Matteo, De Mattei, Monica
Publicado 2021

Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets

por Pasquini, Silvia, Contri, Chiara, Merighi, Stefania, Gessi, Stefania, Borea, Pier Andrea, Varani, Katia, Vincenzi, Fabrizio
Publicado 2022

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

por Papa, Alessandro, Pasquini, Silvia, Contri, Chiara, Gemma, Sandra, Campiani, Giuseppe, Butini, Stefania, Varani, Katia, Vincenzi, Fabrizio
Publicado 2022

Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors. Ranging from Pan Ligands to Combined A1/A2B Partial Agonists

por Catarzi, Daniela, Varano, Flavia, Varani, Katia, Vincenzi, Fabrizio, Pasquini, Silvia, Dal Ben, Diego, Volpini, Rosaria, Colotta, Vittoria
Publicado 2019

Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes

por Pasquini, Silvia, Vincenzi, Fabrizio, Casetta, Ilaria, Laudisi, Michele, Merighi, Stefania, Gessi, Stefania, Borea, Pier Andrea, Varani, Katia
Publicado 2020

A(2A) Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity?

por Merighi, Stefania, Nigro, Manuela, Travagli, Alessia, Pasquini, Silvia, Borea, Pier Andrea, Varani, Katia, Vincenzi, Fabrizio, Gessi, Stefania
Publicado 2022

An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?

por Merighi, Stefania, Poloni, Tino Emanuele, Pelloni, Lucia, Pasquini, Silvia, Varani, Katia, Vincenzi, Fabrizio, Borea, Pier Andrea, Gessi, Stefania
Publicado 2021

A(2A) Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease

por Gessi, Stefania, Poloni, Tino Emanuele, Negro, Giulia, Varani, Katia, Pasquini, Silvia, Vincenzi, Fabrizio, Borea, Pier Andrea, Merighi, Stefania
Publicado 2021